DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr. Reddy¿s Laboratories Ltd.
02 2Moehs Catalana SL
03 2Aurobindo Pharma Limited
04 1Chromo Laboratories India Private Limited
05 1Cipla Ltd.
06 2Divi's Laboratories Limited
07 1F.I.S. FABBRICA ITALIANA SINTETICI S.P.A.
08 1Hunan Jiudian Pharmaceutical Co.,Ltd.
09 2MSN Pharmachem Private Limited
10 2MYLAN LABORATORIES LIMITED
11 1Quimica Sintetica S.A.
12 2SMS Pharmaceuticals Limited
13 1SUN PHARMACEUTICAL INDUSTRIES, INC.
14 1Tianish Laboratories Private Limited
01 1SUMATRIPTAN
02 5SUMATRIPTAN SUCCINATE
03 3Sumatriptan
04 10Sumatriptan Succinate
05 1Sumatriptan succinate
01 1China
02 13India
03 1Italy
04 3Spain
05 2U.S.A
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-060
Start Marketing Date : 2003-03-21
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
Moehs Group, a reference company in the production of pharmaceutical active ingredients.
NDC Package Code : 52932-0727
Start Marketing Date : 2009-10-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Moehs Group, a reference company in the production of pharmaceutical active ingredients.
NDC Package Code : 52932-0733
Start Marketing Date : 2009-10-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52562-024
Start Marketing Date : 2022-12-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53104-7581
Start Marketing Date : 2016-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 48087-0075
Start Marketing Date : 2010-04-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49574-517
Start Marketing Date : 2019-06-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 50370-0029
Start Marketing Date : 2011-12-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 50370-0014
Start Marketing Date : 2010-04-15
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53069-0560
Start Marketing Date : 2000-04-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Sumatriptan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sumatriptan, including repackagers and relabelers. The FDA regulates Sumatriptan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sumatriptan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sumatriptan manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Sumatriptan supplier is an individual or a company that provides Sumatriptan active pharmaceutical ingredient (API) or Sumatriptan finished formulations upon request. The Sumatriptan suppliers may include Sumatriptan API manufacturers, exporters, distributors and traders.
click here to find a list of Sumatriptan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Sumatriptan as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Sumatriptan API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Sumatriptan as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Sumatriptan and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Sumatriptan NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Sumatriptan suppliers with NDC on PharmaCompass.
We have 14 companies offering Sumatriptan
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
